Drug
Medroxyprogesterone clinical trials
Includes 74 studies of Medroxyprogesterone Acetate.
- studies test it
- 84
- open now
- 9
- in phase 3
- 23
- first study started
- 1996
Keep track of what changes. Save the Medroxyprogesterone studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
83 studies that test it; most in 2015 (9)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 1999 | 1 |
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 6 |
| 2015 | 9 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 9
- Phase 2
- 21
- Phase 3
- 23
- Phase 4
- 24
- No phase
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 75
FHI 360 (5) · Teva Branded Pharmaceutical Products R&D, Inc. (3) · Pfizer (2) · University of Washington (2) · Assiut University (2) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (2) · Gynecologic Oncology Group (2) · Centre Leon Berard (2)
Often tested with
Tested in the same studies.
Estradiol (4) · Levonorgestrel (3) · Conjugated estrogens (3) · Contraceptives, Oral, Combined (2) · Dydrogesterone (2) · Venlafaxine (2) · Megestrol Acetate (2) · Megestrol (2)
Studies
Open first, then newest update. How each study uses Medroxyprogesterone is read from its arms, and is right about nine times in ten.
Testing it · 84
- A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)RecruitingPhase 2Merck Sharp & Dohme LLCNCT06979596Written as Megestrol acetate/Medroxyprogesterone acetate
- Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell DiseaseRecruitingPhase 4University of PennsylvaniaNCT06665997Written as Depot medroxyprogesterone acetate (DMPA)
- Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular ClassificationRecruitingPhase 2/3Fudan UniversityNCT07319429Written as Medroxyprogesterone Acetate 500 MG
- Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-ANot yet recruitingPhase 3ShangHai Ji Ai Genetics & IVF InstituteNCT05326087Written as MPA
- Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and VomitingNot yet recruitingPhase 3The First Affiliated Hospital of Xinxiang Medical CollegeNCT07124195Written as Medroxyprogesterone acetate oral suspension
- Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.Not yet recruitingPhase 4GinefivNCT06637189Written as Medroxyprogesterone Acetate 10 MG
- Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial HyperplasiaRecruitingPhase 2Peking University People's HospitalNCT05675787Written as Medroxyprogesterone acetate + Atorvastatin
- Repurposed Drugs to Improve Haematological Responses in Myelodysplastic SyndromesRecruitingPhase 2Prof. Janet DunnNCT04997811Written as Sodium Valproate, Bezafibrate, Medroxyprogesterone
- Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia PatientsRecruitingPhase 2/3Hua LiNCT05565573Written as Medroxyprogesterone Acetate 500 MG Oral Tablet
- Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion PatientsCompletedPhase 4Northwestern UniversityNCT05505435Written as Depot-Medroxyprogestereone Acetate
- Endometrial Biopsy in Progestin Contraceptive UsersCompletedEarly Phase 1Oregon Health and Science UniversityNCT05760144Written as DMPA
- Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial CancerCompletedPhase 4University of British ColumbiaNCT05651282Written as Provera
- Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: A Pilot StudyCompletedPhase 4University of California, San DiegoNCT06816901Written as Depo Medroxyprogesterone acetate
- A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and AbdomenCompletedPhase 1PfizerNCT04893798Written as Sayana Press
- Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative SurgeryCompletedPhase 3Universitas DiponegoroNCT06145438Written as Depo Medroxyprogesterone acetate
- Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation CyclesCompletedNot applicableBezmialem Vakif UniversityNCT05767086Written as Medroxyprogesterone Acetate (Tarlusal)
- Sayana® Press Extension StudyCompletedPhase 3FHI 360NCT03154125Written as Sayana® Press
- Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal WomenCompletedPhase 1Teva Pharmaceuticals USANCT00830414Written as medroxyprogesterone acetate
- The Kampala Women's Bone StudyCompletedPhase 4University of WashingtonNCT03464266Written as FTC/TDF and DMPA
- Postpartum Family PlanningTerminatedPhase 4Ohio State UniversityNCT03844633Written as Depo-Provera Injectable Product
See all 84 studies that test Medroxyprogesterone →
Given in every arm · 10 — Medroxyprogesterone is usual care beside what is tested
- A Study of TCD601 in de Novo Renal Transplant RecipientsCompletedPhase 2ITB-Med LLCNCT05669001Written as MPA
- Estrogen Receptor Beta and MoodCompletedPhase 2National Institute of Mental Health (NIMH)NCT03689543Written as Provera
- Pilot Study of Femring Estrogen Supplementation During Depo-Provera InitiationCompletedNot applicableColumbia UniversityNCT00563576Written as DepoProvera ®
- Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial CancerCompletedEarly Phase 1National Cancer Institute (NCI)NCT03018249Written as Medroxyprogesterone Acetate
- Research Investigation of Soy and EstrogenCompletedPhase 2University of Illinois at ChicagoNCT00997893Written as Medroxyprogesterone Acetate (MPA)
- Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and SteroidsCompletedPhase 4NovartisNCT00284947Written as MMF/EC-MPS
- Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel UseCompletedPhase 1CONRADNCT01421368Written as Depo-medroxyprogesterone acetate (DMPA)
- Somatropin Treatment to Final Height in Turner SyndromeCompletedPhase 3Eli Lilly and CompanyNCT00191113Written as Medroxyprogesterone acetate
- Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration AddendumCompletedPhase 1/2University of WashingtonNCT00156650Written as Depo-Medroxyprogesterone
- Male Hormonal Contraceptive Development-ACY-5CompletedPhase 1/2University of WashingtonNCT00161447Written as Depo-Medroxyprogesterone
As the comparator · 15 — what is tested is compared with Medroxyprogesterone
- Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist in Controlled Ovarian Stimulation for In Vitro Fertilization: A Randomized Controlled Non-Inferiority Trial With a Concurrent Comparator Cohort Undergoing Progestin-Primed Ovarian Stimulation (PPOS)Not yet recruitingNot applicableCentro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)NCT07732348Written as Medroxyprogesterone Acetate ; Micronized Progesterone
- Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial CancerActive, not recruitingPhase 2Fudan UniversityNCT05247268Written as Medroxyprogesterone Acetate 500 MG
- Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 MonthsWithdrawnPhase 3BayerNCT06904274Written as Medroxyprogesterone acetate
- Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial CancerCompletedPhase 2GOG FoundationNCT02228681Written as Medroxyprogesterone Acetate
- The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic DisorderCompletedPhase 4Far Eastern Memorial HospitalNCT01822288Written as Estradiol & medroxyprogesterone acetate
- Tibolone Endometrium Study (Study 32972)(P06470)CompletedPhase 3Organon and CoNCT00745108Written as CE/MPA
- Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of EndometriosisCompletedPhase 2AbbVieNCT00437658Written as Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)
- Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUBStatus unknownPhase 3Mahidol UniversityNCT02103764Written as Medroxyprogesterone acetate
- Bioidentical 'Natural' Hormone Evaluation in Early MenopauseTerminatedPhase 2Jeanne Drisko, MD, CNS, FACNNCT00302731Written as equine estrogens m-progesteroneacetate
- Lower Dose Depo Provera® Contraceptive InjectionCompletedPhase 1FHI 360NCT02732418Written as Depo-subQ 104
- "Stair Step Study"CompletedPhase 4Radboud University Medical CenterNCT03309176Written as Medroxyprogesterone Acetate 10 MG
- Long-Acting Reversible ContraceptionCompletedPhase 4FHI 360NCT01299116Written as DMPA
- Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy WomenCompletedNot applicableUniversity of Sao PauloNCT00828542Written as depot medroxyprogesterone acetate
- Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)CompletedPhase 3BayerNCT00360490Written as Medroxyprogesterone acetate
- Multi-centre Clinical Trial on Hormone Replacement Treatment in ChinaStatus unknownPhase 4Peking Union Medical College HospitalNCT01698164Written as estradiol plus MPA
Codes
What other systems call Medroxyprogesterone · ClinicalTrials.gg INT007778
- MeSH (NLM) D008525MedroxyprogesteroneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) HSU1C9YRESMEDROXYPROGESTERONEConfirmed FDA, NLM, Wikidata
- RxNorm 6691Confirmed FDA, Wikidata
- Wikidata Q416667medroxyprogesteroneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C629MedroxyprogesteroneConfirmed FDA, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008525 | Medroxyprogesterone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | HSU1C9YRES | MEDROXYPROGESTERONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6691 | — | Confirmed FDA, Wikidata |
| Wikidata | Q416667 | medroxyprogesterone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C629 | Medroxyprogesterone | Confirmed FDA, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.